Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Cl B (HUGE)

Fsd Pharma Inc Cl B (HUGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fsd Pharma Inc Cl B FIRST CANADIAN PLACE 100 KING STREET WEST SUITE 4000 TORONTO A6 M5X 1A4 CAN

www.fsdpharma.com P: 416-854-8884

Description:

FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 19,255
Enterprise Value, $K 16,495
Shares Outstanding, K 39,377
Annual Sales, $ 0 K
Annual Net Income, $ -17,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,390 K
EBIT, $ -21,290 K
EBITDA, $ -18,780 K
60-Month Beta 0.59
% of Insider Shareholders 8.53%
% of Institutional Shareholders 1.24%
Float, K 36,018
% Float 91.47%
Short Volume Ratio 0.43

Growth:

1-Year Return -69.62%
3-Year Return -72.83%
5-Year Return -98.59%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 03/28/24
Latest Earnings Date 05/10/24
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year 75.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-201 on 10/16/19

HUGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -112.38%
Return-on-Assets % -82.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.42
Book Value/Share 0.33
Interest Coverage -0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar